APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital Injectable Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hospital Injectable Drugs Industry Growth and Trends Forecast to 2032

21 December 2025121 pages

Choose your research edition.

Industry ResearchHospital Injectable Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital Injectable Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Hospital Injectable Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital Injectable Drugs Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital Injectable Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

According to APO Research, the global Hospital Injectable Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Hospital Injectable Drugs market include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent) and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hospital Injectable Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hospital Injectable Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hospital Injectable Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hospital Injectable Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Hospital Injectable Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hospital Injectable Drugs Market by Company

Hospira (Pfizer Inc.)

Baxter

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Otsuka

B.Braun

JW Life Science

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Sichuan Kelun Pharmaceutical

Cisen Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Shandong Hualu Pharmaceutical

CR Double-Crane

Hospital Injectable Drugs Segment by Type

Generic Sterile Injectables

Sterile Intravenous (IV) Solutions

Hospital Injectable Drugs Segment by Application

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

Hospital Injectable Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Injectable Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Hospital Injectable Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Hospital Injectable Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Hospital Injectable Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Hospital Injectable Drugs Market Share by Region (2021-2026) Table 4. Global Hospital Injectable Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Hospital Injectable Drugs Market Share by Region (2027-2032) Table 6. Global Hospital Injectable Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hospital Injectable Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Hospital Injectable Drugs Market Size Share by Type (2021-2026) Table 9. Global Hospital Injectable Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Hospital Injectable Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Hospital Injectable Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Hospital Injectable Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Hospital Injectable Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Hospital Injectable Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Hospital Injectable Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Hospital Injectable Drugs Market Size Share by Application (2021-2026) Table 24. Global Hospital Injectable Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Hospital Injectable Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Hospital Injectable Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Hospital Injectable Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Hospital Injectable Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Hospital Injectable Drugs Industry Trends Table 37. Hospital Injectable Drugs Industry Drivers Table 38. Hospital Injectable Drugs Industry Opportunities and Challenges Table 39. Hospital Injectable Drugs Industry Restraints Table 40. Global Hospital Injectable Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Hospital Injectable Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Hospital Injectable Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Hospital Injectable Drugs Key Company Headquarters & Area Served Table 44. Global Hospital Injectable Drugs Company, Product Type & Application Table 45. Global Hospital Injectable Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Hospital Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Hospira (Pfizer Inc.) Company Information Table 49. Hospira (Pfizer Inc.) Business Overview Table 50. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Portfolio Table 52. Hospira (Pfizer Inc.) Recent Development Table 53. Baxter Company Information Table 54. Baxter Business Overview Table 55. Baxter Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Baxter Hospital Injectable Drugs Product Portfolio Table 57. Baxter Recent Development Table 58. Fresenius Kabi Company Information Table 59. Fresenius Kabi Business Overview Table 60. Fresenius Kabi Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Fresenius Kabi Hospital Injectable Drugs Product Portfolio Table 62. Fresenius Kabi Recent Development Table 63. Sandoz (Novartis) Company Information Table 64. Sandoz (Novartis) Business Overview Table 65. Sandoz (Novartis) Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio Table 67. Sandoz (Novartis) Recent Development Table 68. Hikma Pharmaceuticals PLC Company Information Table 69. Hikma Pharmaceuticals PLC Business Overview Table 70. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio Table 72. Hikma Pharmaceuticals PLC Recent Development Table 73. Dr. Reddy’s Laboratories Ltd Company Information Table 74. Dr. Reddy’s Laboratories Ltd Business Overview Table 75. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Portfolio Table 77. Dr. Reddy’s Laboratories Ltd Recent Development Table 78. Grifols Company Information Table 79. Grifols Business Overview Table 80. Grifols Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Grifols Hospital Injectable Drugs Product Portfolio Table 82. Grifols Recent Development Table 83. Nichi-Iko Group (Sagent) Company Information Table 84. Nichi-Iko Group (Sagent) Business Overview Table 85. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio Table 87. Nichi-Iko Group (Sagent) Recent Development Table 88. Teva Pharmaceutical Company Information Table 89. Teva Pharmaceutical Business Overview Table 90. Teva Pharmaceutical Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 92. Teva Pharmaceutical Recent Development Table 93. Otsuka Company Information Table 94. Otsuka Business Overview Table 95. Otsuka Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Otsuka Hospital Injectable Drugs Product Portfolio Table 97. Otsuka Recent Development Table 98. B.Braun Company Information Table 99. B.Braun Business Overview Table 100. B.Braun Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. B.Braun Hospital Injectable Drugs Product Portfolio Table 102. B.Braun Recent Development Table 103. JW Life Science Company Information Table 104. JW Life Science Business Overview Table 105. JW Life Science Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. JW Life Science Hospital Injectable Drugs Product Portfolio Table 107. JW Life Science Recent Development Table 108. Auromedics Company Information Table 109. Auromedics Business Overview Table 110. Auromedics Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Auromedics Hospital Injectable Drugs Product Portfolio Table 112. Auromedics Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sanofi Hospital Injectable Drugs Product Portfolio Table 117. Sanofi Recent Development Table 118. Gland Pharma Company Information Table 119. Gland Pharma Business Overview Table 120. Gland Pharma Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Gland Pharma Hospital Injectable Drugs Product Portfolio Table 122. Gland Pharma Recent Development Table 123. Endo International PLC Company Information Table 124. Endo International PLC Business Overview Table 125. Endo International PLC Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Endo International PLC Hospital Injectable Drugs Product Portfolio Table 127. Endo International PLC Recent Development Table 128. Sichuan Kelun Pharmaceutical Company Information Table 129. Sichuan Kelun Pharmaceutical Business Overview Table 130. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 132. Sichuan Kelun Pharmaceutical Recent Development Table 133. Cisen Pharmaceutical Company Information Table 134. Cisen Pharmaceutical Business Overview Table 135. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cisen Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 137. Cisen Pharmaceutical Recent Development Table 138. Shijiazhuang No. 4 Pharmaceutical Company Information Table 139. Shijiazhuang No. 4 Pharmaceutical Business Overview Table 140. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 142. Shijiazhuang No. 4 Pharmaceutical Recent Development Table 143. Shandong Hualu Pharmaceutical Company Information Table 144. Shandong Hualu Pharmaceutical Business Overview Table 145. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio Table 147. Shandong Hualu Pharmaceutical Recent Development Table 148. CR Double-Crane Company Information Table 149. CR Double-Crane Business Overview Table 150. CR Double-Crane Hospital Injectable Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. CR Double-Crane Hospital Injectable Drugs Product Portfolio Table 152. CR Double-Crane Recent Development Table 153. North America Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Hospital Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Hospital Injectable Drugs Market Share by Country (2021-2026) Table 156. North America Hospital Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Hospital Injectable Drugs Market Share Forecast by Country (2027-2032) Table 158. Europe Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Hospital Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Hospital Injectable Drugs Market Share by Country (2021-2026) Table 161. Europe Hospital Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Hospital Injectable Drugs Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Hospital Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Hospital Injectable Drugs Market Share by Country (2021-2026) Table 166. Asia-Pacific Hospital Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Hospital Injectable Drugs Market Share Forecast by Country (2027-2032) Table 168. Latin America Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Hospital Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Hospital Injectable Drugs Market Share by Country (2021-2026) Table 171. Latin America Hospital Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Hospital Injectable Drugs Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2021-2026) Table 176. Middle East & Africa Hospital Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Hospital Injectable Drugs Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Hospital Injectable Drugs Product Image Figure 3. Global Hospital Injectable Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Hospital Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Hospital Injectable Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Hospital Injectable Drugs Market Share by Region (2021-2032) Figure 7. North America Hospital Injectable Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Hospital Injectable Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Hospital Injectable Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Hospital Injectable Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Hospital Injectable Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Generic Sterile Injectables Image Figure 13. Global Generic Sterile Injectables Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Sterile Intravenous (IV) Solutions Image Figure 15. Global Sterile Intravenous (IV) Solutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Hospital Injectable Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Hospital Injectable Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Hospital Injectable Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Hospital Injectable Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Hospital Injectable Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Hospital Injectable Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Hospital Injectable Drugs Market Size Share by Type (2021-2032) Figure 23. Oncology Image Figure 24. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Anesthesia Image Figure 26. Global Anesthesia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Anti-Infectives Image Figure 28. Global Anti-Infectives Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Parenteral Nutrition Image Figure 30. Global Parenteral Nutrition Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Cardiovascular Diseases Image Figure 32. Global Cardiovascular Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Hospital Injectable Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hospital Injectable Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Hospital Injectable Drugs Market Size Share by Application (2021-2032) Figure 36. Europe Hospital Injectable Drugs Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Hospital Injectable Drugs Market Size Share by Application (2021-2032) Figure 38. Latin America Hospital Injectable Drugs Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Hospital Injectable Drugs Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Hospital Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Hospital Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 45. Europe Hospital Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hospital Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 48. Asia-Pacific Hospital Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Hospital Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 51. Latin America Hospital Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Hospital Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 54. Middle East & Africa Hospital Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Hospital Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Sterile Injectables
  • Sterile Intravenous (IV) Solutions
Applications
  • Oncology
  • Anesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular Diseases
Companies covered
  • Hospira (Pfizer Inc.)
  • Baxter
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy’s Laboratories Ltd
  • Grifols
  • Nichi-Iko Group (Sagent)
  • Teva Pharmaceutical
  • Otsuka
  • B.Braun
  • JW Life Science
  • Auromedics
  • Sanofi
  • Gland Pharma
  • Endo International PLC
  • Sichuan Kelun Pharmaceutical
  • Cisen Pharmaceutical
  • Shijiazhuang No. 4 Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • CR Double-Crane

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Hospital Injectable Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Hospital Injectable Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Hospital Injectable Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Hospital Injectable Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Hospital Injectable Drugs Market Size (2021-2032)
  8. 1.5.1 North America Hospital Injectable Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Hospital Injectable Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Hospital Injectable Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Hospital Injectable Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Hospital Injectable Drugs Market Size Growth Rate (2021-2032)
2 Hospital Injectable Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Generic Sterile Injectables
  3. 2.1.2 Sterile Intravenous (IV) Solutions
  4. 2.2 Global Hospital Injectable Drugs Market Size by Type
  5. 2.2.1 Global Hospital Injectable Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Hospital Injectable Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Hospital Injectable Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Hospital Injectable Drugs Market Size by Regions
  9. 2.3.1 North America Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Type (2021-2026)
3 Hospital Injectable Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncology
  3. 3.1.2 Anesthesia
  4. 3.1.3 Anti-Infectives
  5. 3.1.4 Parenteral Nutrition
  6. 3.1.5 Cardiovascular Diseases
  7. 3.2 Global Hospital Injectable Drugs Market Size by Application
  8. 3.2.1 Global Hospital Injectable Drugs Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Hospital Injectable Drugs Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Hospital Injectable Drugs Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Hospital Injectable Drugs Market Size by Regions
  12. 3.3.1 North America Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Hospital Injectable Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Hospital Injectable Drugs Industry Trends
  2. 4.2 Hospital Injectable Drugs Industry Drivers
  3. 4.3 Hospital Injectable Drugs Industry Opportunities and Challenges
  4. 4.4 Hospital Injectable Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Hospital Injectable Drugs Revenue (2021-2026)
  2. 5.2 Global Hospital Injectable Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Hospital Injectable Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Hospital Injectable Drugs Company, Product Type & Application
  5. 5.5 Global Hospital Injectable Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Hospital Injectable Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Hospital Injectable Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Hospital Injectable Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Hospira (Pfizer Inc.)
  2. 6.1.1 Hospira (Pfizer Inc.) Company Information
  3. 6.1.2 Hospira (Pfizer Inc.) Business Overview
  4. 6.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Portfolio
  6. 6.1.5 Hospira (Pfizer Inc.) Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Hospital Injectable Drugs Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi Hospital Injectable Drugs Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Sandoz (Novartis)
  20. 6.4.1 Sandoz (Novartis) Company Information
  21. 6.4.2 Sandoz (Novartis) Business Overview
  22. 6.4.3 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio
  24. 6.4.5 Sandoz (Novartis) Recent Developments
  25. 6.5 Hikma Pharmaceuticals PLC
  26. 6.5.1 Hikma Pharmaceuticals PLC Company Information
  27. 6.5.2 Hikma Pharmaceuticals PLC Business Overview
  28. 6.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio
  30. 6.5.5 Hikma Pharmaceuticals PLC Recent Developments
  31. 6.6 Dr. Reddy’s Laboratories Ltd
  32. 6.6.1 Dr. Reddy’s Laboratories Ltd Company Information
  33. 6.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
  34. 6.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Portfolio
  36. 6.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments
  37. 6.7 Grifols
  38. 6.7.1 Grifols Company Information
  39. 6.7.2 Grifols Business Overview
  40. 6.7.3 Grifols Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Grifols Hospital Injectable Drugs Product Portfolio
  42. 6.7.5 Grifols Recent Developments
  43. 6.8 Nichi-Iko Group (Sagent)
  44. 6.8.1 Nichi-Iko Group (Sagent) Company Information
  45. 6.8.2 Nichi-Iko Group (Sagent) Business Overview
  46. 6.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio
  48. 6.8.5 Nichi-Iko Group (Sagent) Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Otsuka
  56. 6.10.1 Otsuka Company Information
  57. 6.10.2 Otsuka Business Overview
  58. 6.10.3 Otsuka Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Otsuka Hospital Injectable Drugs Product Portfolio
  60. 6.10.5 Otsuka Recent Developments
  61. 6.11 B.Braun
  62. 6.11.1 B.Braun Company Information
  63. 6.11.2 B.Braun Business Overview
  64. 6.11.3 B.Braun Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 B.Braun Hospital Injectable Drugs Product Portfolio
  66. 6.11.5 B.Braun Recent Developments
  67. 6.12 JW Life Science
  68. 6.12.1 JW Life Science Company Information
  69. 6.12.2 JW Life Science Business Overview
  70. 6.12.3 JW Life Science Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 JW Life Science Hospital Injectable Drugs Product Portfolio
  72. 6.12.5 JW Life Science Recent Developments
  73. 6.13 Auromedics
  74. 6.13.1 Auromedics Company Information
  75. 6.13.2 Auromedics Business Overview
  76. 6.13.3 Auromedics Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Auromedics Hospital Injectable Drugs Product Portfolio
  78. 6.13.5 Auromedics Recent Developments
  79. 6.14 Sanofi
  80. 6.14.1 Sanofi Company Information
  81. 6.14.2 Sanofi Business Overview
  82. 6.14.3 Sanofi Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sanofi Hospital Injectable Drugs Product Portfolio
  84. 6.14.5 Sanofi Recent Developments
  85. 6.15 Gland Pharma
  86. 6.15.1 Gland Pharma Company Information
  87. 6.15.2 Gland Pharma Business Overview
  88. 6.15.3 Gland Pharma Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Gland Pharma Hospital Injectable Drugs Product Portfolio
  90. 6.15.5 Gland Pharma Recent Developments
  91. 6.16 Endo International PLC
  92. 6.16.1 Endo International PLC Company Information
  93. 6.16.2 Endo International PLC Business Overview
  94. 6.16.3 Endo International PLC Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Endo International PLC Hospital Injectable Drugs Product Portfolio
  96. 6.16.5 Endo International PLC Recent Developments
  97. 6.17 Sichuan Kelun Pharmaceutical
  98. 6.17.1 Sichuan Kelun Pharmaceutical Company Information
  99. 6.17.2 Sichuan Kelun Pharmaceutical Business Overview
  100. 6.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio
  102. 6.17.5 Sichuan Kelun Pharmaceutical Recent Developments
  103. 6.18 Cisen Pharmaceutical
  104. 6.18.1 Cisen Pharmaceutical Company Information
  105. 6.18.2 Cisen Pharmaceutical Business Overview
  106. 6.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Product Portfolio
  108. 6.18.5 Cisen Pharmaceutical Recent Developments
  109. 6.19 Shijiazhuang No. 4 Pharmaceutical
  110. 6.19.1 Shijiazhuang No. 4 Pharmaceutical Company Information
  111. 6.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
  112. 6.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio
  114. 6.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments
  115. 6.20 Shandong Hualu Pharmaceutical
  116. 6.20.1 Shandong Hualu Pharmaceutical Company Information
  117. 6.20.2 Shandong Hualu Pharmaceutical Business Overview
  118. 6.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio
  120. 6.20.5 Shandong Hualu Pharmaceutical Recent Developments
  121. 6.21 CR Double-Crane
  122. 6.21.1 CR Double-Crane Company Information
  123. 6.21.2 CR Double-Crane Business Overview
  124. 6.21.3 CR Double-Crane Hospital Injectable Drugs Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 CR Double-Crane Hospital Injectable Drugs Product Portfolio
  126. 6.21.5 CR Double-Crane Recent Developments
7 North America
  1. 7.1 North America Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Hospital Injectable Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Hospital Injectable Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Hospital Injectable Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Hospital Injectable Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Hospital Injectable Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Hospital Injectable Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Hospital Injectable Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Hospital Injectable Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Hospital Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Hospital Injectable Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst